Kirsten Pier, MBA

Process development and manufacturing leader with 20+ years of operator experience across biologics and gene therapy, from large biopharma (Amgen, Shire) to gene therapy biotech (bluebird bio, Axovant Gene Therapies) to CDMO (Jubilant HollisterStier) to consulting (BioTechLogic, now her own TKD Solutions practice).

Deep specialty in lentiviral vector manufacturing, gene therapy process development and CMC, biologics process engineering, and manufacturing investigations. Held the VP, Process Development & Manufacturing seat at Axovant Gene Therapies through the Axovant-to-Sio transition. Now runs TKD Solutions as Owner and Principal Consultant.